Literature DB >> 12655417

Clinical data and cerebrospinal fluid findings in Lyme meningitis versus aseptic meningitis.

David Tuerlinckx1, Eddy Bodart2, Maria-Grazia Garrino3, Georges de Bilderling2.   

Abstract

The purpose of this study was to characterise Lyme meningitis (LM) in a Belgian paediatric population and to suggest findings that could allow early distinction from aseptic meningitis (AM). The medical records of patients hospitalised between 1993 and 2000 and with a discharge diagnosis of LM (n=14) or AM (n=16) were retrospectively reviewed. The Kruskal-Wallis test was used to compare data. Of the patients, 16 were identified with AM and 14 with LM, amongst which 7 presented with isolated LM and 7 with associated peripheral facial palsy (PFP). Patients with AM, when compared with LM, complained of more pronounced signs and symptoms of meningitis (fever, headaches, and neck stiffness); they statistically displayed a shorter period of symptoms before admission (1.6 vs 15 days), higher neutrophilic component (mean 56% vs 2.4%), and lower protein levels (mean 0.39 vs 1.12 g/l) on cerebrospinal fluid analysis. In the neuroborreliosis group, the duration of symptoms was shorter and the cerebrospinal protein level was lower in cases of LM associated with PFP compared to isolated LM (mean 1.3 vs 15 days; mean 0.55 g/l vs 1.12 g/l). Conclusions. Our results suggest that some clinical data and laboratory findings may help the physician to diagnose aseptic or Lyme meningitis before completion of serologic testing. LM should be suspected in cases of meningitis with very low CSF neutrophilic counts and high protein levels associated with prolonged duration of symptoms, low grade fever, and absence of pronounced signs of meningitis.

Entities:  

Mesh:

Year:  2003        PMID: 12655417     DOI: 10.1007/s00431-002-1119-1

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  14 in total

Review 1.  Lyme disease.

Authors:  A C Steere
Journal:  N Engl J Med       Date:  2001-07-12       Impact factor: 91.245

2.  A European multicenter study of immunoblotting in serodiagnosis of lyme borreliosis.

Authors:  J Robertson; E Guy; N Andrews; B Wilske; P Anda; M Granström; U Hauser; Y Moosmann; V Sambri; J Schellekens; G Stanek; J Gray
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

3.  Characterization of Lyme meningitis and comparison with viral meningitis in children.

Authors:  S C Eppes; D K Nelson; L L Lewis; J D Klein
Journal:  Pediatrics       Date:  1999-05       Impact factor: 7.124

4.  Diagnostic value of cerebrospinal fluid examination in children with peripheral facial palsy and suspected Lyme borreliosis.

Authors:  M Albisetti; G Schaer; M Good; E Boltshauser; D Nadal
Journal:  Neurology       Date:  1997-09       Impact factor: 9.910

5.  Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1995-08-11       Impact factor: 17.586

6.  Long-term cognitive effects of Lyme disease in children.

Authors:  W V Adams; C D Rose; S C Eppes; J D Klein
Journal:  Appl Neuropsychol       Date:  1999

7.  Successful oral doxycycline treatment of Lyme disease-associated facial palsy and meningitis.

Authors:  L Dotevall; L Hagberg
Journal:  Clin Infect Dis       Date:  1999-03       Impact factor: 9.079

8.  Neurocognitive abnormalities in children after classic manifestations of Lyme disease.

Authors:  B J Bloom; P M Wyckoff; H C Meissner; A C Steere
Journal:  Pediatr Infect Dis J       Date:  1998-03       Impact factor: 2.129

9.  The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis.

Authors:  A R Pachner; A C Steere
Journal:  Neurology       Date:  1985-01       Impact factor: 9.910

10.  An epidemiologic study of Lyme disease in southern Sweden.

Authors:  J Berglund; R Eitrem; K Ornstein; A Lindberg; A Ringér; H Elmrud; M Carlsson; A Runehagen; C Svanborg; R Norrby
Journal:  N Engl J Med       Date:  1995-11-16       Impact factor: 91.245

View more
  9 in total

Review 1.  Bacterial meningitis: diagnosis and treatment.

Authors:  Russell D Snyder
Journal:  Curr Neurol Neurosci Rep       Date:  2003-11       Impact factor: 5.081

2.  [Lactobacillus rhamnosus GG conditioned medium prevents E. coli meningitis by inhibiting nuclear factor-κB pathway].

Authors:  Qing Zeng; Xiao-Long He; Han-Sheng Xiao; Lei Du; Yu-Jing Li; Le-Cheng Chen; Hui-Wen Tian; Sheng-He Huang; Hong Cao
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-01-20

Review 3.  What we have learned about Lyme borreliosis from studies in children.

Authors:  Sunil K Sood
Journal:  Wien Klin Wochenschr       Date:  2006-11       Impact factor: 1.704

Review 4.  Aseptic meningitis: diagnosis and management.

Authors:  Rashmi Kumar
Journal:  Indian J Pediatr       Date:  2005-01       Impact factor: 5.319

Review 5.  Chronic Lyme disease: misconceptions and challenges for patient management.

Authors:  John J Halperin
Journal:  Infect Drug Resist       Date:  2015-05-15       Impact factor: 4.003

6.  The recomBead Borrelia antibody index, CXCL13 and total IgM index for laboratory diagnosis of Lyme neuroborreliosis in children.

Authors:  B H Skogman; M Lager; A J Henningsson; I Tjernberg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-07-20       Impact factor: 3.267

7.  The NeBoP score - a clinical prediction test for evaluation of children with Lyme Neuroborreliosis in Europe.

Authors:  Barbro H Skogman; Johanna Sjöwall; Per-Eric Lindgren
Journal:  BMC Pediatr       Date:  2015-12-17       Impact factor: 2.125

8.  Occurrence of erythema migrans in children with Lyme neuroborreliosis and the association with clinical characteristics and outcome - a prospective cohort study.

Authors:  Kesia Backman; Barbro H Skogman
Journal:  BMC Pediatr       Date:  2018-06-11       Impact factor: 2.125

9.  The chemokine CXCL13 in cerebrospinal fluid in children with Lyme neuroborreliosis.

Authors:  Anna J Henningsson; Malin Lager; Rebecka Brännström; Ivar Tjernberg; Barbro H Skogman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-08-06       Impact factor: 3.267

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.